BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 29554790)

  • 1. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
    Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of metastatic lymph nodes ratio in overall survival for patients with resected nonsmall cell lung cancer: a retrospective cohort study.
    Lin X; Yao J; Huang B; Chen T; Xie L; Huang R
    Eur J Cancer Prev; 2024 Jul; 33(4):376-385. PubMed ID: 38842873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database.
    Jia B; Zheng Q; Wang J; Sun H; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Yang X; Zhong J; Chen H; Chi Y; Zhai X; Wang Z
    BMC Cancer; 2020 Jul; 20(1):666. PubMed ID: 32680464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram to Predict Occult N2 Lymph Nodes Metastases in Patients With Squamous Nonsmall Cell Lung Cancer.
    Jiang L; Jiang S; Lin Y; Yang H; Xie Z; Lin Y; Long H
    Medicine (Baltimore); 2015 Nov; 94(46):e2054. PubMed ID: 26579815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
    Li H; Wang Z; Yang F; Wang J
    J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer: A Multiinstitutional Study.
    Zhang Y; Zheng D; Xie J; Li Y; Wang Y; Li C; Xiang J; Zhang Y; Hu H; Sun Y; Chen H
    Chest; 2018 Sep; 154(3):501-511. PubMed ID: 29758181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nomogram to predict prognosis after surgery in early stage non-small cell lung cancer in elderly patients.
    Sun F; Ma K; Yang X; Li M; Shi Y; Zhan C; Jiang W; Wang Q
    Int J Surg; 2017 Jun; 42():11-16. PubMed ID: 28428062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database.
    Chen X; Pang Z; Wang Y; Bie F; Zeng Y; Wang G; Du J
    Lung Cancer; 2020 Jan; 139():94-102. PubMed ID: 31759223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
    Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
    Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer.
    Liang W; Zhang L; Jiang G; Wang Q; Liu L; Liu D; Wang Z; Zhu Z; Deng Q; Xiong X; Shao W; Shi X; He J
    J Clin Oncol; 2015 Mar; 33(8):861-9. PubMed ID: 25624438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
    Huang X; Hu P; Yan F; Zhang J
    Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
    [No Abstract]   [Full Text] [Related]  

  • 15. A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy.
    Han H; Zhao Y; Gao Z; Zheng D; Fu F; Zhao Z; Tang Y; Xiang J; Sun Y; Hu H; Chen H
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2115-2122. PubMed ID: 31175463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
    Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
    Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The advanced lung cancer inflammation index (ALI) predicted the postoperative survival rate of patients with non-small cell lung cancer and the construction of a nomogram model.
    Ma S; Li Z; Wang L
    World J Surg Oncol; 2024 Jun; 22(1):158. PubMed ID: 38877553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram to predict overall survival after gallbladder cancer resection in China.
    Bai Y; Liu ZS; Xiong JP; Xu WY; Lin JZ; Long JY; Miao F; Huang HC; Wan XS; Zhao HT
    World J Gastroenterol; 2018 Dec; 24(45):5167-5178. PubMed ID: 30568393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefits associated with surgery for advanced non-small cell lung cancer.
    David EA; Andersen SW; Beckett LA; Melnikow J; Clark JM; Brown LM; Cooke DT; Kelly K; Canter RJ
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1620-1628. PubMed ID: 30551965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.